| Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH‐dependent solubility the Achilles heel of targeted therapy? NR Budha, A Frymoyer, GS Smelick, JY Jin, MR Yago, MJ Dresser, ... Clinical Pharmacology & Therapeutics 92 (2), 203-213, 2012 | 346 | 2012 |
| 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer N Nagy, HF Kuipers, AR Frymoyer, HD Ishak, JB Bollyky, TN Wight, ... Frontiers in immunology 6, 123, 2015 | 296 | 2015 |
| Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug–drug interaction potential for molecular targeted agents in clinical development GS Smelick, TP Heffron, L Chu, B Dean, DA West, SL DuVall, BL Lum, ... Molecular pharmaceutics 10 (11), 4055-4062, 2013 | 175 | 2013 |
| Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate A Frymoyer, AL Hersh, LZ Benet, BJ Guglielmo The Pediatric infectious disease journal 28 (5), 398-402, 2009 | 175 | 2009 |
| Association between vancomycin trough concentration and area under the concentration-time curve in neonates A Frymoyer, AL Hersh, MH El-Komy, S Gaskari, F Su, DR Drover, ... Antimicrobial agents and chemotherapy 58 (11), 6454-6461, 2014 | 143 | 2014 |
| Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections A Frymoyer, BJ Guglielmo, AL Hersh The Pediatric infectious disease journal 32 (10), 1077-1079, 2013 | 141 | 2013 |
| Model‐informed precision dosing at the bedside: scientific challenges and opportunities RJ Keizer, R Ter Heine, A Frymoyer, LJ Lesko, R Mangat, S Goswami CPT: pharmacometrics & systems pharmacology 7 (12), 785-787, 2018 | 101 | 2018 |
| Clinical monitoring of well-appearing infants born to mothers with chorioamnionitis NS Joshi, A Gupta, JM Allan, RS Cohen, JL Aby, B Weldon, JL Kim, ... Pediatrics 141 (4), 2018 | 69 | 2018 |
| Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia A Frymoyer, L Meng, SL Bonifacio, D Verotta, BJ Guglielmo Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (7 …, 2013 | 64 | 2013 |
| Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria MR Yago, AR Frymoyer, GS Smelick, LA Frassetto, NR Budha, ... Molecular pharmaceutics 10 (11), 4032-4037, 2013 | 58 | 2013 |
| Predictive performance of a vancomycin population pharmacokinetic model in neonates C Stockmann, AL Hersh, JK Roberts, J Bhongsatiern, EK Korgenski, ... Infectious Diseases and Therapy 4, 187-198, 2015 | 57 | 2015 |
| Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation A Frymoyer, AL Hersh, Z Coralic, LZ Benet, BJ Guglielmo Clinical therapeutics 32 (3), 534-542, 2010 | 54 | 2010 |
| Delayed distribution of active vasodilation and altered vascular conductance in aged skin JM Pierzga, A Frymoyer, WL Kenney Journal of Applied Physiology 94 (3), 1045-1053, 2003 | 53 | 2003 |
| Decreased morphine clearance in neonates with hypoxic ischemic encephalopathy receiving hypothermia A Frymoyer, SL Bonifacio, DR Drover, F Su, CJ Wustoff, KP Van Meurs The Journal of Clinical Pharmacology 57 (1), 64-76, 2017 | 52 | 2017 |
| Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women BJ Dong, Y Zheng, MD Hughes, A Frymoyer, D Verotta, P Lizak, F Sawe, ... Aids 26 (7), 833-841, 2012 | 51 | 2012 |
| Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations A Frymoyer, BJ Guglielmo, SD Wilson, SB Scarpace, LZ Benet, AL Hersh Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31 (9 …, 2011 | 51 | 2011 |
| The use of betaine HCl to enhance dasatinib absorption in healthy volunteers with rabeprazole-induced hypochlorhydria MR Yago, A Frymoyer, LZ Benet, GS Smelick, LA Frassetto, X Ding, ... The AAPS journal 16, 1358-1365, 2014 | 50 | 2014 |
| Model-informed precision dosing of vancomycin in hospitalized children: implementation and adoption at an academic children’s hospital A Frymoyer, HT Schwenk, Y Zorn, L Bio, JD Moss, B Chasmawala, ... Frontiers in Pharmacology 11, 551, 2020 | 48 | 2020 |
| The pharmacokinetics and dosing of oral 4-methylumbelliferone for inhibition of hyaluronan synthesis in mice HF Kuipers, N Nagy, SM Ruppert, VG Sunkari, PL Marshall, JA Gebe, ... Clinical & Experimental Immunology 185 (3), 372-381, 2016 | 48 | 2016 |
| Individualized empiric vancomycin dosing in neonates using a model-based approach A Frymoyer, C Stockmann, AL Hersh, S Goswami, RJ Keizer Journal of the Pediatric Infectious Diseases Society 8 (2), 97-104, 2019 | 44 | 2019 |
Benet lzUCSFVerified email at ucsf.edu
